The microbiome as ally in the fight against cancer
The gut microbiome influences cancer risk, treatment response, and side effect profiles. From colorectal cancer to immunotherapy outcomes, microbiome science is reshaping oncology — and clinical trials are uncovering how to harness it.
View Recruiting TrialsHow Cancer & the Microbiome relates to gut health
The microbiome affects cancer through multiple pathways: by modulating the immune system's tumor-fighting ability, by producing metabolites that can either protect or damage DNA, and by influencing whether immunotherapy drugs work. Patients with higher microbiome diversity tend to respond better to checkpoint inhibitors. FMT from responders to non-responders is being tested in trials.
We’ll email you when new recruiting trials for your condition are posted. No spam, ever.